Moderna to Pursue $2B Private Offering of 2032 Convertible Notes
MRNA Moderna Inc
$149.66 -5.77%
View chart & analysis → - 1Moderna (MRNA) to pursue $2B aggregate principal private offering of convertible notes due 2032
- 2Underwriters granted option to purchase additional $300M; settlement in cash, shares, or combination at company's election
- 3Net proceeds to fund capped call transactions (capped at minimum 150% premium) to offset dilution, plus oncology and debt repayment
This 3-line summary is compiled from the report below.
ACCESSWIRE +1 View original ↗
오늘의 AI 픽 5종목, 무료로 전부 공개합니다숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다